Ventyx Biosciences IPO

Ventyx Biosciences advances a broad pipeline of potent and selective small-molecule drug candidates to treat inflammatory diseases and autoimmune disorders.

Register for Details

For more details on financing and valuation for Ventyx Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Ventyx Biosciences's ticker symbol?


What is Ventyx Biosciences's stock price?

34.73 as of 9/29/23

Learn more about Ventyx Biosciences

Forge green plus iconForge green minus icon

When was Ventyx Biosciences founded?

Ventyx Biosciences was founded in 2018.
Updated on: Jun 12, 2022